Tech Company Financing Transactions
Tragara Pharmaceuticals Funding Round
On 7/20/2015, Tragara Pharmaceuticals secured $1.2 million in funding from private investors.
Transaction Overview
Company Name
Announced On
7/20/2015
Transaction Type
Debt
Amount
$1,201,200
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3152 Lionshead Ave.
Carlsbad, CA 92010
USA
Carlsbad, CA 92010
USA
Phone
Website
Email Address
Overview
Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of cancer and inflammation-related diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tracy Parrott
Chief Financial Officer
Dennis Bilski
VP - Bus. Development
Chris LeMasters
VP - Manufacturing
Stuart Gallant
Browse more venture capital transactions:
Prev: 7/20/2015: Sensity Systems venture capital transaction
Next: 7/20/2015: NanoMersion venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs